News Daily News Type 2 MI Linked to More CV Deaths, Even in Younger Patients Shelley Wood March 04, 2020
News Daily News Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk Yael L. Maxwell March 03, 2020
News Daily News Trials of New Cancer Drugs Failing to Address Potential CV Risks Todd Neale February 10, 2020
News Daily News Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis Caitlin E. Cox February 07, 2020
News Daily News Most Secondary Prevention Patients Are Eligible for Multiple Drugs Michael O'Riordan January 03, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2019 Shelley Wood December 31, 2019
News Daily News CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials Caitlin E. Cox December 11, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Conference News AHA 2019 Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE Yael L. Maxwell November 21, 2019
News Conference News AHA 2019 ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD Todd Neale November 16, 2019
News Opinion Off Script AHA 2019 Off Script: Will ISCHEMIA Answer Our Most Pressing Questions? Ajay Kirtane, MD, SM November 12, 2019
News Daily News Women More Likely Than Men to Develop Heart Failure After STEMI L.A. McKeown November 04, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2019 Todd Neale October 31, 2019
News Conference News AHA 2019 ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain Shelley Wood October 25, 2019
News Daily News DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis Michael O'Riordan October 17, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News Dramatic Swings in Household Income Linked to CVD Risk: ARIC Michael O'Riordan October 09, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2019 Shelley Wood October 01, 2019
News Conference News TCT 2019 IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease Michael O'Riordan September 26, 2019
News Industry News CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019 September 25, 2019